Browse Data and Analysis

Vietnam is a growing market for beef and beef products, with demand driven by numerous factors including a growing population, economic growth, widening integration with global economies through free trade agreements, rising income per capita, and expanding modern retail and food service channels.

Hungary is one of the strongest opponents of transgenic engineering. Maintaining the country’s GE-free status remains a government priority.

This report describes the agricultural biotechnology sector in Spain, covering production and trade, policy, and marketing aspects.

The Government of Bulgaria (GOB) continues to oppose agricultural biotechnology. Non-governmental anti-biotech organizations, local activists, and Bulgaria’s organics industry actively spread nonscientific disinformation about biotechnology.

There are no significant changes to the agricultural biotechnology situation in the Czech Republic in 2023. The country generally maintains a scientific approach towards biotechnology and became a vocal advocate for their adoption in the EU during its EU Council presidency.

This report assesses the agricultural biotechnology sector in Belgium for plants, animals, and microorganisms. Belgium's stance on agricultural biotechnology differs between the regions of Wallonia and Flanders, with the latter being more receptive.

This report describes production, trade, research, policy, and marketing issues of genetically engineered (GE) plants, animal products, and microbial biotechnology in Italy.

While acceptance of innovative biotechnologies is gaining some traction within informed stakeholder groups, Austria continues to be one of the leading forces in Europe opposed to the use of agricultural biotechnology.

Agricultural biotechnology constitutes an opportunity for U.S. suppliers, as non-governmental and governmental organizations have encouraged its integration into the Haitian economy in recent years.

Over a dozen Caribbean countries are Parties to the Cartagena Protocol on Biosafety. With an aim toward meeting their obligations under this agreement, many have been working toward establishing their National Biosafety Frameworks for many years.

While Colombia´s regulatory environment remains friendly toward the adoption of biotechnology-derived crops and products, congressional anti-biotechnology initiatives pose a threat to further acceptance, and risk undermining future investments to benefit consumers and the agricultural sector.

While Colombia´s regulatory environment remains friendly toward the adoption of biotechnology-derived crops and products, congressional anti-biotechnology initiatives pose a threat to further acceptance, and risk undermining future investments to benefit consumers and the agricultural sector.